Commutability limitations influence quality control results with different reagent lots

W. Greg Miller, Aybala Erek, Tina D. Cunningham, Olajumoke Oladipo, Mitchell G. Scott, Robert E. Johnson

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

BACKGROUND: Good laboratory practice includes verifying that each new lot of reagents is suitable for use before it is put into service. Noncommutability of quality control (QC) samples with clinical patient samples may preclude their use to verify consistency of results for patient samples between different reagent lots. METHODS: Patient sample results and QC data were obtained from reagent lot change verification records for 18 QC materials, 661 reagent lot changes, 1483 reagent lot change-QC events, 82 analytes, and 7 instrument platforms. The significance of between-lot differences in the results for QC samples compared with those for patient samples was assessed by a modified 2-sample t test adjusted for heterogeneity ofQCand patient sample measurement variances. RESULTS: Overall, 40.9% of reagent lot change-QC events had a significant difference (P< 0.05) between results for QC samples compared with results for patient samples between 2 reagent lots. For QC results with differences<1.0 SD interval (83.1% of total), 37.7% were significantly different from the changes observed for patient samples. For QC results with differences<1.0 SD interval (16.9% of total), 57.0% were significantly different from those for patient samples. CONCLUSIONS: Occurrence of noncommutable results for QC materials was frequent enough that the QC results could not be used to verify consistency of results for patient samples when changing lots of reagents.

Original languageEnglish (US)
Pages (from-to)76-83
Number of pages8
JournalClinical Chemistry
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Quality Control
Quality control

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Miller, W. Greg ; Erek, Aybala ; Cunningham, Tina D. ; Oladipo, Olajumoke ; Scott, Mitchell G. ; Johnson, Robert E. / Commutability limitations influence quality control results with different reagent lots. In: Clinical Chemistry. 2011 ; Vol. 57, No. 1. pp. 76-83.
@article{a9ac8e9899914c41bddf751e7552a574,
title = "Commutability limitations influence quality control results with different reagent lots",
abstract = "BACKGROUND: Good laboratory practice includes verifying that each new lot of reagents is suitable for use before it is put into service. Noncommutability of quality control (QC) samples with clinical patient samples may preclude their use to verify consistency of results for patient samples between different reagent lots. METHODS: Patient sample results and QC data were obtained from reagent lot change verification records for 18 QC materials, 661 reagent lot changes, 1483 reagent lot change-QC events, 82 analytes, and 7 instrument platforms. The significance of between-lot differences in the results for QC samples compared with those for patient samples was assessed by a modified 2-sample t test adjusted for heterogeneity ofQCand patient sample measurement variances. RESULTS: Overall, 40.9{\%} of reagent lot change-QC events had a significant difference (P< 0.05) between results for QC samples compared with results for patient samples between 2 reagent lots. For QC results with differences<1.0 SD interval (83.1{\%} of total), 37.7{\%} were significantly different from the changes observed for patient samples. For QC results with differences<1.0 SD interval (16.9{\%} of total), 57.0{\%} were significantly different from those for patient samples. CONCLUSIONS: Occurrence of noncommutable results for QC materials was frequent enough that the QC results could not be used to verify consistency of results for patient samples when changing lots of reagents.",
author = "Miller, {W. Greg} and Aybala Erek and Cunningham, {Tina D.} and Olajumoke Oladipo and Scott, {Mitchell G.} and Johnson, {Robert E.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1373/clinchem.2010.148106",
language = "English (US)",
volume = "57",
pages = "76--83",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "1",

}

Commutability limitations influence quality control results with different reagent lots. / Miller, W. Greg; Erek, Aybala; Cunningham, Tina D.; Oladipo, Olajumoke; Scott, Mitchell G.; Johnson, Robert E.

In: Clinical Chemistry, Vol. 57, No. 1, 01.01.2011, p. 76-83.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Commutability limitations influence quality control results with different reagent lots

AU - Miller, W. Greg

AU - Erek, Aybala

AU - Cunningham, Tina D.

AU - Oladipo, Olajumoke

AU - Scott, Mitchell G.

AU - Johnson, Robert E.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - BACKGROUND: Good laboratory practice includes verifying that each new lot of reagents is suitable for use before it is put into service. Noncommutability of quality control (QC) samples with clinical patient samples may preclude their use to verify consistency of results for patient samples between different reagent lots. METHODS: Patient sample results and QC data were obtained from reagent lot change verification records for 18 QC materials, 661 reagent lot changes, 1483 reagent lot change-QC events, 82 analytes, and 7 instrument platforms. The significance of between-lot differences in the results for QC samples compared with those for patient samples was assessed by a modified 2-sample t test adjusted for heterogeneity ofQCand patient sample measurement variances. RESULTS: Overall, 40.9% of reagent lot change-QC events had a significant difference (P< 0.05) between results for QC samples compared with results for patient samples between 2 reagent lots. For QC results with differences<1.0 SD interval (83.1% of total), 37.7% were significantly different from the changes observed for patient samples. For QC results with differences<1.0 SD interval (16.9% of total), 57.0% were significantly different from those for patient samples. CONCLUSIONS: Occurrence of noncommutable results for QC materials was frequent enough that the QC results could not be used to verify consistency of results for patient samples when changing lots of reagents.

AB - BACKGROUND: Good laboratory practice includes verifying that each new lot of reagents is suitable for use before it is put into service. Noncommutability of quality control (QC) samples with clinical patient samples may preclude their use to verify consistency of results for patient samples between different reagent lots. METHODS: Patient sample results and QC data were obtained from reagent lot change verification records for 18 QC materials, 661 reagent lot changes, 1483 reagent lot change-QC events, 82 analytes, and 7 instrument platforms. The significance of between-lot differences in the results for QC samples compared with those for patient samples was assessed by a modified 2-sample t test adjusted for heterogeneity ofQCand patient sample measurement variances. RESULTS: Overall, 40.9% of reagent lot change-QC events had a significant difference (P< 0.05) between results for QC samples compared with results for patient samples between 2 reagent lots. For QC results with differences<1.0 SD interval (83.1% of total), 37.7% were significantly different from the changes observed for patient samples. For QC results with differences<1.0 SD interval (16.9% of total), 57.0% were significantly different from those for patient samples. CONCLUSIONS: Occurrence of noncommutable results for QC materials was frequent enough that the QC results could not be used to verify consistency of results for patient samples when changing lots of reagents.

UR - http://www.scopus.com/inward/record.url?scp=78650973954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650973954&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2010.148106

DO - 10.1373/clinchem.2010.148106

M3 - Article

C2 - 21097677

AN - SCOPUS:78650973954

VL - 57

SP - 76

EP - 83

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 1

ER -